Kehealarepresents a breakthrough in improving patient adherence because it goes beyond a daily reminder: it bolsters the social support network for vulnerable patients, improving quality of life while curing disease. With Keheala, patients and clinicians have the tools they need to overcome the social drivers of non-adherence. Compared to the status quo in TB treatment and the WHO’s desired protocol, DOTS, Keheala represents a scalable, cost-effective solution, which saves money while saving lives.

Without a need to preload the platform to a device, compatibility with 99% of all mobile devices and eight out of ten individuals in Africa already owning a mobile phone, Keheala can quickly be accessed from a mobile phone anywhere, today. The social science principles used are universal and designed to cut across cultures. The robust, yet, flexibletechnology used is ideal for scaling across markets and keeping the solution cost-effective.

As the first compliance technology to address the social factors at the root of Tuberculosis epidemiology, Keheala offers an unprecedented opportunity to improve treatment rates and thus decrease morbidity, mortality, transmission, and MDR-TB. Keheala has the potential to revise what we consider acceptable success rates in Tuberculosis treatment, and it epitomizes the ideal public health intervention, so rarely realized: improved health outcomes with reduced costs.